SCOPUS 정보 검색 플랫폼

Drug Safety

Volumn 12, Issue 4, 1995, Pages 227-233

What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions?

(2) Sansom, Lloyd N a Evans, Allan M a

a UNIVERSITY OF SOUTH AUSTRALIA (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALFENTANIL; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BUPRENORPHINE; CHLORAL HYDRATE; CLOFIBRATE; DESIPRAMINE; DIFLUNISAL; DISOPYRAMIDE; FENTANYL; HYDRALAZINE; IMIPRAMINE; LIDOCAINE; METHADONE; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; OROSOMUCOID; PHENYLBUTAZONE; PHENYTOIN; PROPRANOLOL; ROXITHROMYCIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VERAPAMIL; WARFARIN;

DRUG CLEARANCE; EDITORIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PLASMA PROTEIN BINDING; PRIORITY JOURNAL;

BINDING, COMPETITIVE; BIOLOGICAL AVAILABILITY; BLOOD PROTEINS; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; DRUG MONITORING; HUMAN; IN VITRO; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PROTEIN BINDING;

EID: 0028942901 PISSN: 01145916 EISSN: 11791942 Source Type: Journal
DOI: 10.2165/00002018-199512040-00001 Document Type: Article

Times cited : (82)

References (28)

1
- 0018363645
- Plasma protein displacement interactions are rarely of clinical significance
- 225, 7
- (1979) Pharmacology , vol.18
- Sellers, E.M.¹

2
- 0003403775
- 2nd, Philadelphia, Lea & Febiger, 255, 75
- (1989) Clinical pharmacokinetics. Concepts and applications
- Rowland, M.¹ Tozer, T.²

3
- 0003523134
- 4th, Philadelphia, Lea & Febiger, 305, 43
- (1991) Biopharmaceutics and clinical pharmacokinetics
- Gibaldi, M.¹

4
- 0001077535
- Influence of protein binding and use of unbound (free) drug concentrations
- W.E., Evans, J.J., Schentag, W.J., Jusko, 2nd, Washington, Applied Therapeutics Inc
- (1986) Applied pharmacokinetics. Principles of therapeutic drug monitoring , pp. 187-219
- Svensson, C.K.¹ Woodruff, M.N.² Lalka, D.³

5
- 0003403522
- Oxford, Blackwell Scientific
- (1981) Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management
- Stockley, I.H.¹

6
- 67651107807
- Philadelphia, Lea & Febiger
- (1985) Drug interactions: clinical significance of drug interactions
- Hansten, P.D.¹

7
- 80051870481
- Clinically important drug interactions
- G.S., Avery, 3rd, Auckland, Adis Press, 255, 82
- (1987) Drug treatment
- Prescott, L.F.¹

8
- 0024513791
- Protein binding displacement interactions. Fact or fiction?
- (1989) Clin Pharmacokinet , vol.16 , pp. 65-73
- MacKichan, J.J.¹

9
- 0027197018
- Plasma protein binding and pharmacological response
- 435, 40
- (1993) Clin Pharmacokinet , vol.24
- du Souich, P.¹ Verges, J.² Erill, S.³

10
- 0028303820
- Plasma protein binding displacement interactions — why are they still regarded as clinically important?
- 125, 8
- (1994) Br J Clin Pharmacol , vol.37
- Rolan, P.E.¹

11
- 0345316843
- Disopyramide
- W.E., Evans, J.J., Schentag, W.J., Jusko, 2nd, Washington, Applied Therapeutics Inc., 1210, 53
- (1986) Applied pharmacokinetics. Principles of therapeutic drug monitoring
- Lima, J.J.¹

12
- 0003942835
- Basingstoke, Macmillan Publishers Ltd
- (1992) Handbook of clinical pharmacokinetic data , pp. 1-132
- Jack, D.B.¹

13
- 0024432794
- Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid
- 327, 44
- (1989) Clin Pharmacokinet , vol.17
- Miners, J.O.¹

14
- 0014950172
- Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate
- 827, 31
- (1970) N Engl J Med , vol.283
- Seller, E.M.¹ Koch-Weser, J.²

15
- 0016242593
- Warfarin-chloral hydrate interaction. Pharmacological activity and clinical significance
- 341, 4
- (1974) Ann Intern Med , vol.81
- Udal, J.A.¹

16
- 0019441454
- Kinetics of drug displacement interactions
- 181, 90
- (1981) J Pharmacokinet Biopharm , vol.9
- Aarons, L.J.¹ Rowland, M.²

17
- 0023132476
- Clearance
- (1987) Pharmacol Rev , vol.39 , pp. 1-47
- Wilkinson, G.R.¹

18
- 0025060127
- Clinical significance of pharmacokinetic models of hepatic elimination
- (1990) Clin Pharmacokinet , vol.18 , pp. 61-76
- Morgan, D.J.¹ Smallwood, R.A.²

19
- 0025064286
- Pharmacokinetic drug interactions with phenytoin (part I)
- (1990) Clin Pharmacokinet , vol.18 , pp. 37-60
- Nation, R.L.¹ Evans, A.M.² Milne, R.W.³

20
- 0018726788
- Decreased plasma protein binding of phenytoin in patients on valproic acid
- 547, 52
- (1979) Br J Clin Pharmacol , vol.8
- Dahlqvist, R.¹ Borga, O.² Rane, A.³

21
- 0018879202
- Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients
- (1980) Clin Pharmacol Ther , vol.27 , pp. 89-95
- Monks, A.¹ Richens, A.²

22
- 0018135172
- Plasma protein binding interaction between phenytoin and valproic acid in vitro
- 487, 92
- (1978) Br J Clin Pharmacol , vol.6
- Monks, A.¹ Boobis, S.² Wadsworth, J.³

23
- 0019149441
- Interaction between diflunisal and warfarin
- 493, 8
- (1980) Clin Pharmacol Ther , vol.28
- Serlin, M.J.¹ Mossman, S.² Sibeon, R.G.³

24
- 0028263164
- Clinically significant drug interactions with the oral anticoagulants
- 381, 94
- (1994) Drug Saf , vol.10
- Freedman, M.D.¹ Olatidoye, A.G.²

25
- 0027991622
- Drug interactions with fibric acids
- 163, 76
- (1994) Pharmacol Ther , vol.63
- Lozada, A.¹ Dujovne, C.A.²

26
- 0018843539
- Stereoselective interaction of phenylbutazone with (12C/13C) warfarin pseudoracemates in man
- 746, 53
- (1980) J Clin Invest , vol.65
- O’Reilly, R.A.¹ Trager, W.F.² Motley, C.H.³

27
- 0016680312
- Warfarin-phenylbutazone interaction in man: a long term multiple-dose study
- 663, 72
- (1975) Res Commun Chem Pathol Pharmacol , vol.10
- Schary, W.L.¹ Lewis, R.J.² Rowland, M.³

28
- 0018732720
- Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction
- 316, 21
- (1979) J Pharmacol Exp Ther , vol.210
- Bjornsson, T.D.¹ Meffin, P.J.² Swezey, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.